CYTOKINETICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cytokinetics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Cytokinetics Inc Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 118M shares, a 20.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 118M +20M +20.4% Nov 5, 2024 10-Q 2024-11-07
Q2 2024 118M +21.7M +22.6% Aug 7, 2024 10-Q 2024-08-09
Q1 2024 103M +7.36M +7.7% Feb 27, 2024 10-K 2024-02-28
Q3 2023 98.1M +3.42M +3.62% Nov 1, 2023 10-Q 2023-11-03
Q2 2023 96M +1.85M +1.97% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 95.6M +9.99M +11.7% May 2, 2023 10-Q 2023-05-05
Q3 2022 94.6M +10.7M +12.8% Nov 2, 2022 10-Q 2022-11-04
Q2 2022 94.1M +10.6M +12.7% Aug 2, 2022 10-Q 2022-08-05
Q1 2022 85.7M +13.9M +19.4% May 4, 2022 10-Q 2022-05-06
Q3 2021 83.9M +13.1M +18.5% Nov 1, 2021 10-Q 2021-11-05
Q2 2021 83.5M +13M +18.5% Aug 2, 2021 10-Q 2021-08-06
Q1 2021 71.7M +12.3M +20.7% May 4, 2021 10-Q 2021-05-07
Q3 2020 70.8M +11.7M +19.8% Nov 2, 2020 10-Q/A 2021-03-11
Q2 2020 70.5M +11.8M +20.2% Aug 3, 2020 10-Q 2020-08-10
Q1 2020 59.5M +4.56M +8.31% Mar 2, 2020 10-K 2020-03-04
Q3 2019 59.1M +4.37M +7.99% Oct 30, 2019 10-Q 2019-11-01
Q2 2019 58.7M +4.05M +7.42% Aug 1, 2019 10-Q 2019-08-09
Q1 2019 54.9M +691K +1.28% Mar 5, 2019 10-K 2019-03-07
Q3 2018 54.7M +826K +1.53% Nov 5, 2018 10-Q 2018-11-09
Q2 2018 54.6M +961K +1.79% Jul 29, 2018 10-Q 2018-08-07
Q1 2018 54.2M +9.11M +20.2% Apr 30, 2018 10-Q 2018-05-10
Q3 2017 53.9M +13.4M +33% Oct 27, 2017 10-Q 2017-11-03
Q2 2017 53.7M +14M +35.2% Jul 27, 2017 10-Q 2017-08-04
Q1 2017 45.1M +5.46M +13.8% Apr 27, 2017 10-Q 2017-05-04
Q3 2016 40.5M +1.67M +4.3% Oct 27, 2016 10-Q/A 2016-12-15
Q2 2016 39.7M +954K +2.46% Jul 28, 2016 10-Q 2016-08-04
Q1 2016 39.6M +904K +2.34% Apr 28, 2016 10-Q 2016-05-05
Q3 2015 38.8M +2.24M +6.12% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 38.8M +2.14M +5.85% Jul 30, 2015 10-Q 2015-08-05
Q1 2015 38.7M +2.64M +7.31% Apr 28, 2015 10-Q 2015-05-04
Q3 2014 36.6M +7.11M +24.1% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 36.6M +7.26M +24.7% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 36.1M -113M -75.7% Feb 28, 2014 10-K 2014-03-07
Q3 2013 29.5M -113M -79.3% Oct 25, 2013 10-Q 2013-11-06
Q2 2013 29.4M -104M -78% Jul 26, 2013 10-Q 2013-08-07
Q1 2013 149M +71.1M +91.7% Apr 26, 2013 10-Q 2013-05-08
Q3 2012 142M +70.1M +97% Oct 25, 2012 10-Q 2012-11-07
Q2 2012 133M +61.2M +84.7% Jul 23, 2012 10-Q 2012-08-06
Q1 2012 77.5M Apr 27, 2012 10-Q 2012-05-04
Q3 2011 72.3M Oct 28, 2011 10-Q 2011-11-04
Q2 2011 72.3M Jul 29, 2011 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.